QA: Melinta Therapeutics INC NEW in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001461993_2013_Melinta_Therapeutics_INC_NEW.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001461993, Melinta Therapeutics INC NEW

  xvar xval
0 AssetsCurrent 70,373,735
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 43,217
3 remainder_Assets 321,394
4 LiabilitiesCurrent 5,344,709
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,623,285
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,562,460
9 ResearchAndDevelopmentExpense 83,727,560
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 70,738,346
1 Liabilities 12,967,994
2 Expenses 105,290,020
3 Revenues 0
4 StockholdersEquity 57,770,352
5 NetIncome -105,290,020
6 ComprehensiveNetIncome -105,290,020
7 BaseVar 94,498,180
8 EconomicCapitalRatiobeforeLimitedLiability 0.493
9 EconomicCapitalRatio 1.88

Edgar->Model Mapping

Feature Distribution